Stay updated with breaking news from Platform Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ivermectin neither reduced hospital admissions for worsening COVID-19 nor shortened the time that infected patients spent in the emergency room, according to data from a large randomized controlled trial.
A new Aussie research program kicking off this week will investigate the most effective, long-term strategies for booster vaccinations.
A team of Australia’s top infectious disease experts will lead a clinical trial to determine whether combining different Covid-19 vaccines in the nation’s booster immunisation will increase effectiveness. The three-year project has been funded by a m
A team of Australia’s top infectious disease experts will lead a clinical trial to determine whether combining different Covid-19 vaccines in the
Biohaven Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Developments - NURTEC® ODT (rimegepant) net product revenues for the fourth quarter of 2020 were $35.1 million, representing a 98% increase compared to the third quarter of 2020, and $63.6 million for calendar year 2020 following U.S. commercial launch in March of 2020 - Exceeded market expectations with robust growth of NURTEC ODT totaling over 337,000 prescriptions in 2020 and over 24,000 unique prescribers - Regulatory filing for rimegepant in Europe submitted and accepted for review by European Medic...